Page last updated: 2024-10-22

acetazolamide and B-Cell Lymphoma

acetazolamide has been researched along with B-Cell Lymphoma in 1 studies

Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Méhes, G1
Matolay, O1
Beke, L1
Czenke, M1
Pórszász, R1
Mikó, E1
Bai, P1
Berényi, E1
Trencsényi, G1

Other Studies

1 other study available for acetazolamide and B-Cell Lymphoma

ArticleYear
Carbonic Anhydrase Inhibitor Acetazolamide Enhances CHOP Treatment Response and Stimulates Effector T-Cell Infiltration in A20/BalbC Murine B-Cell Lymphoma.
    International journal of molecular sciences, 2020, Jul-15, Volume: 21, Issue:14

    Topics: Acetazolamide; Animals; Antineoplastic Combined Chemotherapy Protocols; Carbonic Anhydrase Inhibitor

2020